Natco Pharma

{
  "main_header": {
    "sid": 156274,
    "name": "Natco Pharma",
    "stock_name": "Natco Pharma",
    "full_name": "Natco Pharma Ltd.",
    "name_url": "stocks-analysis/natco-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,016.75",
    "chg": -158.85,
    "chgp": "-13.51%",
    "dir": -1,
    "prev_price": "1,175.60",
    "mcapval": "21,264.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524816,
    "symbol": "NATCOPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE987B01026",
    "curr_date": "May 29",
    "curr_time": "",
    "bse_nse_vol": "41.28 lacs",
    "exc_status": "Active",
    "traded_date": "May 29, 2026",
    "traded_date_str": "2026 05 29",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/natco-pharma-156274-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Natco Pharma Ltd. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-natco-pharma-ltd-latest-results-good-or-bad-4023803",
        "imagepath": "",
        "date": "2026-05-30 19:44:38",
        "description": "Natco Pharma Ltd.'s latest financial results for Q4 FY26 reveal a complex picture of operational performance. The company reported a net profit of ₹267.90 crores, which reflects a significant quarter-on-quarter growth of 76.83%. However, this figure is accompanied by a year-on-year decline of 34.11%, indicating challenges in sustaining profitability over a longer period. \n\nNet sales for the quarter reached ₹739.10 crores, marking a 14.18% increase from the previous quarter, yet this is overshadowed by a substantial year-on-year decrease of 39.47%. This suggests that while there may be some recovery from the previous quarter, the overall trend remains concerning, particularly given the sharp decline in sales compared to the same quarter last year.\n\nThe operating margin, excluding other income, fell to 17.26%, which is noted as a multi-quarter low. This decline in operating margin indicates significant pressu..."
      },
      {
        "title": "Natco Pharma Q4 FY26: Sharp Revenue Decline Overshadows Tax Reversal Gains",
        "link": "https://www.marketsmojo.com/news/result-analysis/natco-pharma-q4-fy26-sharp-revenue-decline-overshadows-tax-reversal-gains-4023587",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NatcoPharma_quaterlyResult_4023587.png",
        "date": "2026-05-30 12:16:10",
        "description": "Natco Pharma Ltd. reported consolidated net profit of ₹267.90 crores for the quarter ended March 2026, marking a sharp 76.83% quarter-on-quarter surge but a concerning 34.11% year-on-year decline. The Hyderabad-based pharmaceutical manufacturer, with a market capitalisation of ₹21,264 crores, witnessed its stock plummet 13.51% following the results announcement, closing at ₹1,016.75 on May 29, 2026. The quarter's performance reveals a troubling divergence: whilst net profit appeared robust due to a significant tax reversal, core operational metrics deteriorated substantially, with revenues declining 39.47% year-on-year to ₹739.10 crores and operating margins compressing to multi-quarter lows."
      },
      {
        "title": "Natco Pharma Ltd. Hits Intraday Low Amid Price Pressure on 29 May 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-hits-intraday-low-amid-price-pressure-on-29-may-2026-4020637",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NatcoPharmaLtd_priceRelatedfactors_4020637.png",
        "date": "2026-05-29 14:31:13",
        "description": "Natco Pharma Ltd. experienced a notable decline today, hitting an intraday low of Rs 1085.4, reflecting a sharp price correction amid broader market weakness and sector underperformance. The stock closed with a significant loss, underperforming both its sector and the benchmark Sensex."
      },
      {
        "title": "Natco Pharma Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-ltd-is-rated-hold-by-marketsmojo-4018075",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NatcoPharmaLtd_mojoScore_4018075.png",
        "date": "2026-05-28 10:10:04",
        "description": "Natco Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 May 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Natco Pharma Ltd.?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-natco-pharma-ltd-3999686",
        "imagepath": "",
        "date": "2026-05-19 23:17:41",
        "description": "The next results date for Natco Pharma Ltd. is scheduled for 29 May 2026...."
      },
      {
        "title": "Natco Pharma Ltd. is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-ltd-is-rated-hold-3995470",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NatcoPharmaLtd_mojoScore_3995470.png",
        "date": "2026-05-17 10:10:03",
        "description": "Natco Pharma Ltd. is rated 'Hold' by MarketsMOJO, a rating that was last updated on 10 March 2026. While this rating change occurred in early March, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Natco Pharma Ltd. to 52-Week High of Rs 1226.1",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-hits-new-52-week-high-at-rs12261-3987046",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NatcoPharmaLtd_priceRelatedfactors_3987046.png",
        "date": "2026-05-12 09:40:07",
        "description": "With a 42.7% gain over the past year, Natco Pharma Ltd. has surged to a fresh 52-week high of Rs 1226.1 on 12 May 2026, defying the broader market’s downward trend. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and robust price momentum."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Natco Pharma Ltd. to 52-Week High of Rs 1191.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-hits-new-52-week-high-at-rs11915-3981085",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NatcoPharmaLtd_priceRelatedfactors_3981085.png",
        "date": "2026-05-08 09:40:04",
        "description": "With a decisive surge to Rs 1191.5 on 8 May 2026, Natco Pharma Ltd. has reached a fresh 52-week high, extending its impressive rally that has delivered 47.35% returns over the past year. This milestone comes amid a backdrop of strong technical momentum, with the stock outperforming its sector and trading comfortably above all key moving averages."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Natco Pharma Ltd. to 52-Week High of Rs 1174.75",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-ltd-hits-new-52-week-high-at-rs117475-3979751",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NatcoPharmaLtd_priceRelatedfactors_3979751.png",
        "date": "2026-05-07 11:10:03",
        "description": "With a sustained five-day rally culminating in a fresh 52-week high of Rs 1174.75 on 7 May 2026, Natco Pharma Ltd. has demonstrated remarkable price momentum, outpacing its sector and the broader market over the past year."
      }
    ],
    "total": 5647,
    "sid": "156274",
    "stock_news_url": "https://www.marketsmojo.com/news/natco-pharma-156274"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31St March 2026",
      "datetime": "29-May-2026",
      "details": "Audited Financial Results for the quarter and year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "29-May-2026",
      "details": "FY26 Earnings Call Investor Presentation",
      "source": "BSE"
    },
    {
      "caption": "Audited Financial Results For The Quarte And Year Ended 31St March 2026",
      "datetime": "29-May-2026",
      "details": "Audited Financial Results for the quarter and year ended 31st March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has declared <strong>75%</strong> dividend, ex-date: 18 Feb 26",
          "dt": "2026-02-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has announced <strong>2:10</strong> stock split, ex-date: 26 Nov 15",
          "dt": "2015-11-26",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Natco Pharma Ltd. latest results good or bad?

2026-05-30 19:44:38

Natco Pharma Ltd.'s latest financial results for Q4 FY26 reveal a complex picture of operational performance. The company reported a net profit of ₹267.90 crores, which reflects a significant quarter-on-quarter growth of 76.83%. However, this figure is accompanied by a year-on-year decline of 34.11%, indicating challenges in sustaining profitability over a longer period. Net sales for the quarter reached ₹739.10 crores, marking a 14.18% increase from the previous quarter, yet this is overshadowed by a substantial year-on-year decrease of 39.47%. This suggests that while there may be some recovery from the previous quarter, the overall trend remains concerning, particularly given the sharp decline in sales compared to the same quarter last year. The operating margin, excluding other income, fell to 17.26%, which is noted as a multi-quarter low. This decline in operating margin indicates significant pressu...

Read full news article

Natco Pharma Q4 FY26: Sharp Revenue Decline Overshadows Tax Reversal Gains

2026-05-30 12:16:10

Natco Pharma Ltd. reported consolidated net profit of ₹267.90 crores for the quarter ended March 2026, marking a sharp 76.83% quarter-on-quarter surge but a concerning 34.11% year-on-year decline. The Hyderabad-based pharmaceutical manufacturer, with a market capitalisation of ₹21,264 crores, witnessed its stock plummet 13.51% following the results announcement, closing at ₹1,016.75 on May 29, 2026. The quarter's performance reveals a troubling divergence: whilst net profit appeared robust due to a significant tax reversal, core operational metrics deteriorated substantially, with revenues declining 39.47% year-on-year to ₹739.10 crores and operating margins compressing to multi-quarter lows.

Read full news article

Natco Pharma Ltd. Hits Intraday Low Amid Price Pressure on 29 May 2026

2026-05-29 14:31:13

Natco Pharma Ltd. experienced a notable decline today, hitting an intraday low of Rs 1085.4, reflecting a sharp price correction amid broader market weakness and sector underperformance. The stock closed with a significant loss, underperforming both its sector and the benchmark Sensex.

Read full news article

Natco Pharma Ltd. is Rated Hold by MarketsMOJO

2026-05-28 10:10:04

Natco Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

When is the next results date for Natco Pharma Ltd.?

2026-05-19 23:17:41

The next results date for Natco Pharma Ltd. is scheduled for 29 May 2026....

Read full news article

Natco Pharma Ltd. is Rated Hold

2026-05-17 10:10:03

Natco Pharma Ltd. is rated 'Hold' by MarketsMOJO, a rating that was last updated on 10 March 2026. While this rating change occurred in early March, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Natco Pharma Ltd. to 52-Week High of Rs 1226.1

2026-05-12 09:40:07

With a 42.7% gain over the past year, Natco Pharma Ltd. has surged to a fresh 52-week high of Rs 1226.1 on 12 May 2026, defying the broader market’s downward trend. This milestone caps a sustained rally fuelled by a confluence of bullish technical indicators and robust price momentum.

Read full news article

Broad-Based Technical Strength Lifts Natco Pharma Ltd. to 52-Week High of Rs 1191.5

2026-05-08 09:40:04

With a decisive surge to Rs 1191.5 on 8 May 2026, Natco Pharma Ltd. has reached a fresh 52-week high, extending its impressive rally that has delivered 47.35% returns over the past year. This milestone comes amid a backdrop of strong technical momentum, with the stock outperforming its sector and trading comfortably above all key moving averages.

Read full news article

Broad-Based Technical Strength Lifts Natco Pharma Ltd. to 52-Week High of Rs 1174.75

2026-05-07 11:10:03

With a sustained five-day rally culminating in a fresh 52-week high of Rs 1174.75 on 7 May 2026, Natco Pharma Ltd. has demonstrated remarkable price momentum, outpacing its sector and the broader market over the past year.

Read full news article

View All News